Splenic sympathetic signaling contributes to acute neutrophil infiltration of the injured spinal cord.


Journal

Journal of neuroinflammation
ISSN: 1742-2094
Titre abrégé: J Neuroinflammation
Pays: England
ID NLM: 101222974

Informations de publication

Date de publication:
23 Sep 2020
Historique:
received: 14 04 2020
accepted: 26 08 2020
entrez: 24 9 2020
pubmed: 25 9 2020
medline: 30 7 2021
Statut: epublish

Résumé

Alterations in the immune system are a complication of spinal cord injury (SCI) and have been linked to an excessive sympathetic outflow to lymphoid organs. Still unknown is whether these peripheral immune changes also contribute for the deleterious inflammatory response mounted at the injured spinal cord. We analyzed different molecular outputs of the splenic sympathetic signaling for the first 24 h after a thoracic compression SCI. We also analyzed the effect of ablating the splenic sympathetic signaling to the innate immune and inflammatory response at the spleen and spinal cord 24 h after injury. We found that norepinephrine (NE) levels were already raised at this time-point. Low doses of NE stimulation of splenocytes in vitro mainly affected the neutrophils' population promoting an increase in both frequency and numbers. Interestingly, the interruption of the sympathetic communication to the spleen, by ablating the splenic nerve, resulted in reduced frequencies and numbers of neutrophils both at the spleen and spinal cord 1 day post-injury. Collectively, our data demonstrates that the splenic sympathetic signaling is involved in the infiltration of neutrophils after spinal cord injury. Our findings give new mechanistic insights into the dysfunctional regulation of the inflammatory response mounted at the injured spinal cord.

Sections du résumé

BACKGROUND BACKGROUND
Alterations in the immune system are a complication of spinal cord injury (SCI) and have been linked to an excessive sympathetic outflow to lymphoid organs. Still unknown is whether these peripheral immune changes also contribute for the deleterious inflammatory response mounted at the injured spinal cord.
METHODS METHODS
We analyzed different molecular outputs of the splenic sympathetic signaling for the first 24 h after a thoracic compression SCI. We also analyzed the effect of ablating the splenic sympathetic signaling to the innate immune and inflammatory response at the spleen and spinal cord 24 h after injury.
RESULTS RESULTS
We found that norepinephrine (NE) levels were already raised at this time-point. Low doses of NE stimulation of splenocytes in vitro mainly affected the neutrophils' population promoting an increase in both frequency and numbers. Interestingly, the interruption of the sympathetic communication to the spleen, by ablating the splenic nerve, resulted in reduced frequencies and numbers of neutrophils both at the spleen and spinal cord 1 day post-injury.
CONCLUSION CONCLUSIONS
Collectively, our data demonstrates that the splenic sympathetic signaling is involved in the infiltration of neutrophils after spinal cord injury. Our findings give new mechanistic insights into the dysfunctional regulation of the inflammatory response mounted at the injured spinal cord.

Identifiants

pubmed: 32967684
doi: 10.1186/s12974-020-01945-8
pii: 10.1186/s12974-020-01945-8
pmc: PMC7513542
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

282

Subventions

Organisme : Santa Casa da Misericórdia de Lisboa
ID : MC-04/17
Organisme : Fundação para a Ciência e a Tecnologia
ID : CEECIND/01902/2017
Organisme : Fundação para a Ciência e a Tecnologia
ID : SFRH/BD/112494/2015
Organisme : Fundação para a Ciência e a Tecnologia
ID : SFRH/BD/145860/2019
Organisme : Fundação para a Ciência e a Tecnologia
ID : PD/BDE/127836/2016
Organisme : Fundação para a Ciência e a Tecnologia
ID : CEECIND/03887/2017
Organisme : Fundação para a Ciência e a Tecnologia
ID : SFRH/BD/136952/2018
Organisme : Fundação para a Ciência e a Tecnologia
ID : PD/BD/127820/2016
Organisme : Fundação para a Ciência e a Tecnologia
ID : CEECIND/04794/2007
Organisme : Fundação para a Ciência e a Tecnologia
ID : PTDC/DTP-FTO/5109/2014
Organisme : Fundação para a Ciência e a Tecnologia
ID : POCI-01-0145-FEDER-007038
Organisme : Fundação para a Ciência e a Tecnologia
ID : NORTE-01-0145-FEDER-029968
Organisme : Fundação para a Ciência e a Tecnologia
ID : NORTE-01-0145-FEDER-000013

Références

Nat Rev Immunol. 2003 Feb;3(2):159-67
pubmed: 12563299
PLoS Biol. 2018 Oct 17;16(10):e2005264
pubmed: 30332405
PLoS One. 2013 Jul 02;8(7):e69167
pubmed: 23844252
Mol Psychiatry. 2012 Dec;17(12):1295-305
pubmed: 21968930
Brain. 2016 Mar;139(Pt 3):692-707
pubmed: 26754788
Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12912-6
pubmed: 7809145
J Exp Med. 2018 Nov 5;215(11):2778-2795
pubmed: 30282719
Exp Neurol. 2007 Sep;207(1):75-84
pubmed: 17597612
Immunity. 2018 Feb 20;48(2):364-379.e8
pubmed: 29466759
J Neurotrauma. 2006 May;23(5):635-59
pubmed: 16689667
Immunity. 2012 Aug 24;37(2):290-301
pubmed: 22863835
J Immunol. 2013 May 1;190(9):4717-24
pubmed: 23543756
J Neurochem. 2009 Sep;110(5):1409-21
pubmed: 19545280
Nat Med. 2014 Jul;20(7):754-758
pubmed: 24952646
J Exp Med. 2017 May 1;214(5):1333-1350
pubmed: 28424248
J Neurosci. 2020 Jan 8;40(2):478-492
pubmed: 31754014
J Leukoc Biol. 2016 Aug;100(2):253-60
pubmed: 26965635
Front Immunol. 2017 Dec 06;8:1712
pubmed: 29270174
Neuron. 2010 Aug 12;67(3):422-34
pubmed: 20696380
Cell Rep. 2019 Jun 25;27(13):3799-3807.e3
pubmed: 31242414
J Neurosci. 2013 Aug 7;33(32):12970-81
pubmed: 23926252
Immunity. 2018 Jul 17;49(1):93-106.e7
pubmed: 29958804
Brain. 2010 Feb;133(Pt 2):433-47
pubmed: 20085927
Exp Neurol. 2009 Feb;215(2):308-16
pubmed: 19056384
Brain. 2006 Dec;129(Pt 12):3249-69
pubmed: 17071951
Spinal Cord. 2006 Mar;44(3):182-7
pubmed: 16130019
J Neurosci. 2013 Feb 20;33(8):3311-22
pubmed: 23426659
J Exp Med. 2016 Nov 14;213(12):2567-2574
pubmed: 27799619
Nat Commun. 2016 Sep 27;7:13035
pubmed: 27676657
Nat Immunol. 2011 Dec 25;13(2):170-80
pubmed: 22197976
J Neuroimmunol. 2018 Aug 15;321:1-11
pubmed: 29957379
Nat Neurosci. 2016 Jun;19(6):784-7
pubmed: 27089020
J Leukoc Biol. 2000 Apr;67(4):553-8
pubmed: 10770289
Nat Neurosci. 2017 Nov;20(11):1549-1559
pubmed: 28920935
Immunity. 2013 Nov 14;39(5):806-18
pubmed: 24238338
Exp Neurol. 2013 Sep;247:226-40
pubmed: 23664962
Nat Commun. 2019 Sep 20;10(1):4295
pubmed: 31541153
J Leukoc Biol. 2018 Feb;103(2):295-309
pubmed: 29345350
Exp Neurol. 2008 May;211(1):259-70
pubmed: 18384773
Cancer Immunol Immunother. 2017 Apr;66(4):503-513
pubmed: 28108766
J Immunol. 2001 Apr 1;166(7):4348-54
pubmed: 11254688
Science. 2009 Jul 31;325(5940):612-6
pubmed: 19644120
Cell. 2006 Jan 27;124(2):407-21
pubmed: 16439213
Immunol Today. 1998 Dec;19(12):562-7
pubmed: 9864947
J Clin Pathol. 1985 Oct;38(10):1175-8
pubmed: 3902902
Int J Mol Sci. 2019 Aug 01;20(15):
pubmed: 31374824

Auteurs

Susana Monteiro (S)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal.
ICVS/3B's-PT Government Associate Laboratory, Braga, Portugal.

Andreia G Pinho (AG)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal.
ICVS/3B's-PT Government Associate Laboratory, Braga, Portugal.

Mara Macieira (M)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal.
ICVS/3B's-PT Government Associate Laboratory, Braga, Portugal.

Cláudia Serre-Miranda (C)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal.
ICVS/3B's-PT Government Associate Laboratory, Braga, Portugal.

Jorge R Cibrão (JR)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal.
ICVS/3B's-PT Government Associate Laboratory, Braga, Portugal.

Rui Lima (R)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal.
ICVS/3B's-PT Government Associate Laboratory, Braga, Portugal.

Carina Soares-Cunha (C)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal.
ICVS/3B's-PT Government Associate Laboratory, Braga, Portugal.

Natália L Vasconcelos (NL)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal.
ICVS/3B's-PT Government Associate Laboratory, Braga, Portugal.

José Lentilhas-Graça (J)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal.
ICVS/3B's-PT Government Associate Laboratory, Braga, Portugal.

Sara Duarte-Silva (S)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal.
ICVS/3B's-PT Government Associate Laboratory, Braga, Portugal.

Alice Miranda (A)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal.
ICVS/3B's-PT Government Associate Laboratory, Braga, Portugal.

Margarida Correia-Neves (M)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal.
ICVS/3B's-PT Government Associate Laboratory, Braga, Portugal.

António J Salgado (AJ)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal.
ICVS/3B's-PT Government Associate Laboratory, Braga, Portugal.

Nuno A Silva (NA)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal. nunosilva@med.uminho.pt.
ICVS/3B's-PT Government Associate Laboratory, Braga, Portugal. nunosilva@med.uminho.pt.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH